Skip to Main Content

Author Details

Janis E Blair
Mayo Clinic Hospital
1996
148
36
PMIDPaper TitleJournal TitlePublished Year
38009954COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial.Microbiol Spectr2024
36824860Early Treatment, Inflammation and Post-COVID Conditions.medRxiv2023
37755009Serologic Rebound after Stopping Azoles for Primary Pulmonary Coccidioidomycosis: A Case-Controlled Observational Study.J Fungi (Basel)2023
37659419Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.Lancet Microbe2023
37655868Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies.J Clin Microbiol2023
37889989Rare Bipolaris Species Fungal Periprosthetic Hip Infection in an Immunocompetent Host: A Case Report.JBJS Case Connect2023
37534607Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.Transfusion2023
37724870Early antibody treatment, inflammation, and risk of post-COVID conditions.mBio2023
37131659Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.medRxiv2023
36722044Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial.J Infect Dis2023
36443907Resident factors associated with American board of internal medicine certification exam failure.Med Educ Online2023
34651656FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs.Clin Infect Dis2022
35428955Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area.Mycopathologia2022
35717645Controversies in the Management of Central Nervous System Coccidioidomycosis.Clin Infect Dis2022
35353960Early Outpatient Treatment for Covid-19 with Convalescent Plasma.N Engl J Med2022
36107584Impact of COVID-19 on diagnosis of primary pulmonary coccidioidomycosis.Medicine (Baltimore)2022
36354924Fluconazole Failure in the Treatment of Coccidioidal Meningitis.J Fungi (Basel)2022
35914937Do all patients with primary pulmonary coccidioidomycosis need antifungal therapy?Cleve Clin J Med2022
33418569Coccidioidomycosis in patients with various inflammatory disorders treated with tumor necrosis factor α inhibitors.Med Mycol2021
33851175Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma.medRxiv2021
33927679COVID-19 Dysautonomia.Front Neurol2021
33925759Coccidioidomycosis in Allogeneic Stem Cell Transplant Recipients: Case Series and Review of the Literature.J Fungi (Basel)2021
33724424Cavitary Coccidioidomycosis: Impact of azole antifungal therapy.Med Mycol2021
33523609Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.N Engl J Med2021
34981068Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.medRxiv2021
34928960Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.PLoS Med2021
34128896Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness.Medicine (Baltimore)2021
34337097Development of a Quantitative Antigen Assay to Detect Coccidioidal Chitinase-1 (CTS1) in Human Serum.Open Forum Infect Dis2021
31544210Treatment for Early, Uncomplicated Coccidioidomycosis: What Is Success?Clin Infect Dis2020
32000283Pulmonary Coccidioidomycosis.Semin Respir Crit Care Med2020
32861333Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.Mayo Clin Proc2020
32525844Early safety indicators of COVID-19 convalescent plasma in 5000 patients.J Clin Invest2020
32548203Coccidioidomycosis in Patients Treated With Ruxolitinib.Open Forum Infect Dis2020
32511566Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients.medRxiv2020
31578560Coccidioides (spherulin) skin testing in patients with pulmonary coccidioidomycosis in an endemic regionâ¿ .Med Mycol2020
29669037Coccidioidomycosis in selected immunosuppressed hosts.Med Mycol2019
31687463Disseminated coccidioidomycosis mimicking cicatricial alopecia.JAAD Case Rep2019
30229876Cutaneous effects associated with fluconazole in patients treated for coccidioidomycosis.Int J Dermatol2019
30084971The Utility of Screening for Coccidioidomycosis in Recipients of Inhibitors of Tumor Necrosis Factor α.Clin Infect Dis2019
31261704Central Nervous System Infections Due to Coccidioidomycosis.J Fungi (Basel)2019
31286816Pregnancy and Parenting During Cardiology Fellowship.J Am Heart Assoc2019
30811848De novo coccidioidomycosis among solid organ transplant recipients 1 or more years after transplant.Am J Transplant2019
30329094Comparison of two FDA-cleared EIA assays for the detection of Coccidioides antibodies against a composite clinical standard.Med Mycol2019
27557127Integrative Medicine Preferences Among Coccidioidomycosis (Valley Fever) Patients.J Altern Complement Med2017
30591919Oxygen Consumption Deficits in Patients With Residual Fatigue After Primary Coccidioidomycosis.Open Forum Infect Dis2017
28480288Culture-Proven Thorn-Associated Infections in Arizona: 10-Year Experience at Mayo Clinic.Open Forum Infect Dis2017
28452107Neuroinvasive St. Louis Encephalitis Virus Infection in Solid Organ Transplant Recipients.Am J Transplant2017
28419259Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.Clin Infect Dis2017
28695649Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area.Transpl Infect Dis2017
28577242Divergence in the approach to tumor necrosis factor α-inhibitor recipients with coccidioidomycosis.Infection2017
  • 1 - 50 of 148

Recommended Authors

Matthew W McCarthy
Weill Cornell Medical College, New York-Presbyterian Hospital
Career Start Year 2014
Number of shared co-authors 0
Aneesh K Mehta
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Me-Linh Luong
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2008
Number of shared co-authors 0
Wissam El Atrouni
University of Kansas Medical Center
Career Start Year 2006
Number of shared co-authors 2
Ian McHardy
University of California, Davis Center for Valley Fever
Career Start Year 2005
Number of shared co-authors 0
Anurag N Malani
Trinity Health St Joseph Mercy Hospital
Career Start Year 2005
Number of shared co-authors 0
Paschalis Vergidis
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 4
Colleen S Kraft
Emory University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Shahid Husain
University Health Network
Career Start Year 1999
Number of shared co-authors 2
Steven I Aronin
Waterbury Hospital
Career Start Year 1998
Number of shared co-authors 0
Fernanda P Silveira
Federal University of Rio de Janeiro
Career Start Year 1998
Number of shared co-authors 1
George M Lyon
Emory University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Rose Kim
Cooper University Hospital
Career Start Year 1997
Number of shared co-authors 0
Jennifer K Meece
Marshfield Clinic Research Institute, Marshfield Clinic Health System
Career Start Year 1995
Number of shared co-authors 1
Priya Sampathkumar
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 5
Paloma Gij??n
Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM)
Career Start Year 1991
Number of shared co-authors 0
Tony Mazzulli
Mount Sinai Health System and University Health Network
Career Start Year 1989
Number of shared co-authors 0
Jes??s Fort??n
Hospital Universitario Ramon y Cajal
Career Start Year 1988
Number of shared co-authors 0
Daniel J Skiest
University of Massachusetts Medical School-Baystate
Career Start Year 1988
Number of shared co-authors 1
Virginia L Kan
VA Medical Center
Career Start Year 1986
Number of shared co-authors 0
Ben Z Katz
Feinberg School of Medicine, Northwestern University
Career Start Year 1984
Number of shared co-authors 0
Merceditas Villanueva
Yale University
Career Start Year 1984
Number of shared co-authors 0
Matthew Bidwell Goetz
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 1
Coleman Rotstein
University of Toronto, and University Health Network, Toronto General Hospital
Career Start Year 1982
Number of shared co-authors 2
Emilia Mia Sordillo
Icahn School of Medicine at Mount Sinai
Career Start Year 1981
Number of shared co-authors 1
Bernard M Kubak
David Geffen School of Medicine at university of california los angeles
Career Start Year 1981
Number of shared co-authors 0
Peter T Frame
University of Michigan ann arbor
Career Start Year 1976
Number of shared co-authors 0
Bruce S Ribner
Emory University School of Medicine
Career Start Year 1975
Number of shared co-authors 0
Arthur Reingold
University of California berkeley
Career Start Year 1971
Number of shared co-authors 0
George A Sarosi
University of Florida Health
Career Start Year 1961
Number of shared co-authors 0

Collaborators

Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 15
Evan M Bloch
Johns Hopkins University School of Medicine
Co-authored papers 9
Aaron A R Tobian
Johns Hopkins University School of Medicine
Co-authored papers 9
Judith S Currier
David Geffen School of Medicine, University of California los angeles
Co-authored papers 9
Kelly A Gebo
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 9
Andrew Pekosz
Co-authored papers 8
Shmuel Shoham
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 8
Jay S Raval
University of New Mexico
Co-authored papers 7
Matthew R Buras
Mayo Clinic
Co-authored papers 7
Philippe R Bauer
Mayo Clinic
Co-authored papers 6
Matthew N P Vogt
Mayo Clinic
Co-authored papers 6
Michael J Joyner
Mayo Clinic
Co-authored papers 6
Oliver Laeyendecker
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Co-authored papers 6
Katie L Kunze
Mayo Clinic
Co-authored papers 6
Aarthi Shenoy
MedStar Washington Hospital Center
Co-authored papers 6
Jeffrey L Winters
Mayo Clinic
Co-authored papers 6
Chad C Wiggins
Mayo Clinic
Co-authored papers 6
R. Scott Wright
Mayo Clinic
Co-authored papers 6
Allan M Klompas
Mayo Clinic
Co-authored papers 6
Camille M van Buskirk
Mayo Clinic
Co-authored papers 6
Jonathon W Senefeld
University of Illinois at Urbana-Champaign
Co-authored papers 6
Vitaly Herasevich
Belarusian Medical Academy of Postgraduate Education, Belarusian State Medical University, Brest Medical College, Mayo Clinic, Mayo Graduate School
Co-authored papers 6
James R Stubbs
Mayo Clinic
Co-authored papers 6
Katelyn A Bruno
Mayo Clinic
Co-authored papers 6
DeLisa Fairweather
Mayo Clinic
Co-authored papers 6
Nigel Paneth
College of Human Medicine, Michigan State University
Co-authored papers 6
Stephen A Klassen
Brock University
Co-authored papers 6
Kathryn F Larson
Mayo Clinic
Co-authored papers 6
Rickey E Carter
Mayo Clinic
Co-authored papers 6
Patrick W Johnson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 5
Release 1.2